Loading…
Intelligent Bio Solutions Inc. is projected to decline to $2.21 by 2027, a -11% move from its current price of $2.49. INBS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $2.32 | $2.49 | $2.67 | -0.04% |
| May 30 | $2.26 | $2.49 | $2.74 | -0.08% |
| May 31 | $2.21 | $2.49 | $2.80 | -0.13% |
| Jun 1 | $2.17 | $2.49 | $2.85 | -0.17% |
| Jun 2 | $2.13 | $2.48 | $2.90 | -0.21% |
| Jun 3 | $2.10 | $2.48 | $2.94 | -0.25% |
| Jun 4 | $2.07 | $2.48 | $2.98 | -0.30% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.07 | $2.48 | $2.98 | -0.30% |
| Week 2 | $1.91 | $2.48 | $3.21 | -0.59% |
| Week 3 | $1.80 | $2.47 | $3.39 | -0.89% |
| Week 4 | $1.71 | $2.46 | $3.55 | -1.18% |
| Week 5 | $1.63 | $2.45 | $3.69 | -1.47% |
| Week 6 | $1.56 | $2.45 | $3.83 | -1.76% |
| Week 7 | $1.50 | $2.44 | $3.95 | -2.06% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Intelligent Bio Solutions Inc. is a healthcare company focused on developing and delivering non-invasive testing and screening solutions.
It operates an intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse, and a biosensor platform.
The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.
INBS is the asset trading at $2.57 per share, with a market capitalization of $6.15M and a rank of 5288.
The stock sits in the Healthcare sector and is described as a medical technology company focused on non-invasive testing and screening solutions.
Forecasts show a mixed near-term outlook for 2026, with a 2026 min of $2.29, avg of $2.57, max of $3.40 and a Neutral sentiment.
Looking further out, the forecast suggests higher price potential in later years, with 2030 avg $2.39 and 2050 avg $5.39, and corresponding ROIs of -7% in 2030 and 109.9% in 2050.
A major floor 54.1% below — a decisive break under it would weaken the trend.
The nearest floor, 8.0% below — buyers have tended to step in here.
The nearest ceiling, 65.1% above — a clean break opens room to run.
A major ceiling 486.3% above — clearing it would confirm fresh momentum.
Key INBS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of INBS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.63 | Sell | $2.71 | Sell |
| MA 10 | $3.22 | Sell | $2.88 | Sell |
| MA 20 | $2.89 | Sell | $2.92 | Sell |
| MA 50 | $2.91 | Sell | $3.33 | Sell |
| MA 100 | $5.30 | Sell | $4.72 | Sell |
| MA 200 | $7.94 | Sell | $8.11 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 41.08 | Neutral |
| Stoch RSI (14) | 19.31 | Buy |
| CCI (20) | -51.13 | Neutral |
| Williams %R (14) | -89.01 | Info |
| MACD (12,26,9) | -0.06 | Sell |
| ROC (12) | 5.51 | Buy |
| Bollinger %B (20,2) | 0.33 | Neutral |
| Stochastic %K (14) | 10.99 | Buy |
| TRIX (15) | 0.25 | Buy |
| Awesome (5,34) | -0.15 | Sell |
| Ultimate (7,14,28) | 24.15 | Buy |
| Momentum (10) | -0.69 | Sell |
| Aroon Osc (25) | 20.00 | Buy |
| Hull MA (9) | 2.29 | Buy |
| ADX (14) | 25.04 | Sell |
| ATR (14) | 0.20 | Info |
The 30-day technical picture is bearish overall.
RSI14 is 40, indicating modest bearish momentum. The chart shows the 50-day simple moving average at $2.97 and the 200-day simple moving average at $8.07.
Near-term support is listed at $2.29 and resistance at $4.11, with a 30-day trading range from $1.60 to $4.13.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.29 | $2.49 | $3.26 | 0% | Neutral | |
| $1.59 | $2.21 | $3.32 | -11% | Neutral | |
| $1.45 | $2.14 | $3.41 | -14% | Neutral | |
| $1.25 | $1.95 | $3.26 | -22% | Bearish | |
| $1.44 | $2.35 | $4.09 | -6% | Neutral | |
| $1.64 | $2.79 | $5.03 | +12% | Neutral | |
| $1.76 | $3.13 | $5.81 | +26% | Bullish | |
| $1.81 | $3.34 | $6.38 | +34% | Bullish | |
| $1.36 | $2.61 | $5.10 | +5% | Neutral | |
| $1.29 | $2.57 | $5.14 | +3% | Neutral | |
| $1.79 | $3.97 | $8.73 | +59% | Bullish | |
| $2.33 | $5.17 | $11.89 | +108% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $2.29 | $2.49 | $2.97 | +0.00% |
| June 2026 | $2.10 | $2.52 | $3.13 | +1.30% |
| July 2026 | $1.96 | $2.40 | $3.05 | -5.03% |
| August 2026 | $1.97 | $2.44 | $3.17 | +1.83% |
| September 2026 | $2.04 | $2.55 | $3.37 | +4.53% |
| October 2026 | $1.93 | $2.43 | $3.26 | -4.60% |
| November 2026 | $1.80 | $2.30 | $3.11 | -5.63% |
| December 2026 | $1.85 | $2.38 | $3.26 | +3.69% |
Click any year to see its month-by-month INBS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect INBS to range from $2.29 to $3.26 through 2026. The $2.49 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The INBS price prediction for 2027 points to an average of $2.21 (low $1.59, high $3.32) — a potential decline of -11% on today's $2.49. Price action looks broadly range-bound.
In 2028, INBS is projected to trade between $1.45 and $3.41, averaging $2.14 — a potential decline of -14% from today's $2.49. That is -3% versus the projected 2027 average. A consolidation phase looks the most probable path here.
Intelligent Bio Solutions Inc.'s 2029 outlook centres on $1.95, within a $1.25 to $3.26 range. That is -9% versus the projected 2028 average. That marks a -22% change versus current levels. A cyclical pullback looks likely — prices rarely move in a straight line.
By 2030, INBS could reach as high as $4.09, with a base case around $2.35 and support toward $1.44 — roughly -6% from $2.49. A consolidation phase looks the most probable path here.
Expect INBS to range from $1.64 to $5.03 through 2031. The $2.79 average target implies a +12% move from current prices. That is up +19% on the projected 2030 average. Price action looks broadly range-bound.
The INBS price prediction for 2032 points to an average of $3.13 (low $1.76, high $5.81) — a potential gain of +26% on today's $2.49. Buyers look set to stay in control over this stretch.
In 2033, INBS is projected to trade between $1.81 and $6.38, averaging $3.34 — a potential gain of +34% from today's $2.49. That is up +7% on the projected 2032 average. Momentum favours further upside here.
Intelligent Bio Solutions Inc.'s 2034 outlook centres on $2.61, within a $1.36 to $5.10 range. That is -22% versus the projected 2033 average. That marks a +5% change versus current levels. A consolidation phase looks the most probable path here.
By 2035, INBS could reach as high as $5.14, with a base case around $2.57 and support toward $1.29 — roughly +3% from $2.49. Price action looks broadly range-bound.
Expect INBS to range from $1.79 to $8.73 through 2040. The $3.97 average target implies a +59% move from current prices. That is up +55% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The INBS price prediction for 2050 points to an average of $5.17 (low $2.33, high $11.89) — a potential gain of +108% on today's $2.49. Momentum favours further upside here.
Investing $1,000 in INBS today (≈ 401.606426 INBS) could be worth
$2,076.3
+$1,076.3 (+108%) by 2050 · US Dollar
Based on the average projected INBS price of $5.17 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in INBSwould be worth at today's price.
$1,000 invested in INBS on May 27, 2025 (≈ 70.921984 INBS) would be worth
$176.6
-$823.4 (-82.3%) today · 0.18× · US Dollar
Based on a INBS entry price of $14.1 vs. today's $2.49.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.83 | $879.86 | -12.0% |
| 1 month ago | $2.46 | $1,013.84 | +1.4% |
| 3 months ago | $3.91 | $636.83 | -36.3% |
| 6 months ago | $6.6 | $377.27 | -62.3% |
| 1 year ago | $14.1 | $176.6 | -82.3% |
| All time (5.0y) ago | $6,672 | $0.37 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our INBS forecast.
Our base-case forecast reaches $5.00 around 2050.
Implied market cap at $5.00: $11.96M
The multi-year forecast presents a mixed trajectory through the decade. In 2026 the outlook is neutral with an average price of $2.57 and a min of $2.29, a max of $3.40, and ROI of 0%. The 2027 and 2028 forecasts show negative ROI of -12.3% and -13.9% respectively, with neutral sentiment.
From 2030 onward the forecast turns more favorable: 2030 average $2.39 with -7% ROI and Neutral sentiment, then 2031 average $2.90 with 12.8% ROI, and 2032 average $3.26 with 26.8% ROI. 2033 is expected to average $3.41 with a 32.5% ROI and Bullish sentiment.
Higher upside appears in 2040, with an average of $4.11 and a 59.8% ROI, and in 2050 an average of $5.39 with a 109.9% ROI, both labeled Bullish.
These figures are estimates and not guarantees; actual results may vary based on market conditions and other factors.
Tap a question to reveal the answer.
In 2030 the forecast shows min $1.47, avg $2.39, max $4.17, ROI -7%, sentiment Neutral.
The 2026 forecast is avg $2.57 with Neutral sentiment; 2029 shows avg $2.03 with Bearish sentiment and negative ROIs in the near term. The longer horizon shows potential upside with positive ROIs (2031 12.8%, 2032 26.8%, 2033 32.5%, 2040 59.8%, 2050 109.9%). These are estimates, not guarantees.
Yes. The forecast max reaches $5.23 in 2031, $6.06 in 2032, $6.51 in 2033, $9.04 in 2040, and $12.41 in 2050.
Bearish sentiment dominates. RSI 14 is 40, SMA50 is $2.97, SMA200 is $8.07. Support is at $2.29 and resistance at $4.11, with a 30-day range from $1.60 to $4.13.
The company focuses on non-invasive testing and screening solutions, including the intelligent fingerprinting drug screening system and a fingerprint sweat analysis platform, plus a biosensor platform. It was incorporated in 2016 and is headquartered in New York, New York, and it was formerly known as GBS Inc. until October 2022.
Intelligent Bio Solutions Inc. Community Discussion
0Share your Intelligent Bio Solutions Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.